- Research works
- 36 ▼ 88% vs 2013–17
- Citations
- 1.7k 47.8 per fractional work
- Top-10% rate
- 13.1% record average 16.5%
- Open access
- 62% world 28%
Not ranked overall: Cempra Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Cempra Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Antimicrobial Resistance, Clinical Practice Guidelines, Community-Acquired Pneumonia, Pneumococcal Conjugate Vaccine, Antibiotic Resistance, Healthcare-Associated Infections and Virulence Factors.
- Secondary Metabolites
- HIV
- Antibiotics
- Antiretroviral Therapy
- Health Biotechnology
- Diagnosis
- Innovation
- Drug Discovery
- Global Health
- Infectious Diseases
- Drug Resistance
- MRSA
- Antibiotic Pharmacokinetics
- Virulence Factors
- Antibiotic Resistance
- Community-Acquired Pneumonia
- Antimicrobial Resistance
- Epidemiology
- Clinical Practice Guidelines
- Pneumococcal Conjugate Vaccine
- Healthcare-Associated Infections
- Clinical Management
- Critically Ill Patients
- Staphylococcus aureus
- Public Health
- Antimicrobial Stewardship
- Immunocompromised Patients
- ESKAPE Pathogens
- Multidrug-Resistant Bacteria
- Global Collaboration
- Treatment
- Pathogenesis
- Pneumonia
- Pneumocystis
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 34 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 34 words, with their numbers
- Epidemiology14▲ 9.8×17 topics
- Antimicrobial Resistance10▲ 113×4 topics
- Clinical Practice Guidelines5▲ 25×2 topics
- Community-Acquired Pneumonia5▲ 314×1 topic
- Pneumococcal Conjugate Vaccine5▲ 314×1 topic
- Antibiotic Resistance4▲ 31×5 topics
- Healthcare-Associated Infections4▲ 85×3 topics
- Virulence Factors4▲ 53×4 topics
- Clinical Management3▲ 47×2 topics
- Antibiotic Pharmacokinetics3▲ 174×1 topic
- Critically Ill Patients3▲ 174×1 topic
- MRSA3▲ 225×1 topic
- Staphylococcus aureus3▲ 103×1 topic
- Drug Resistance3▲ 23×2 topics
- Public Health3▲ 5.3×2 topics
- Infectious Diseases2▲ 27×2 topics
- Antimicrobial Stewardship2▲ 211×1 topic
- Global Health2▲ 47×1 topic
- Immunocompromised Patients2▲ 79×2 topics
- Drug Discovery2▲ 13×4 topics
- ESKAPE Pathogens2▲ 85×1 topic
- Innovation2▲ 4.9×3 topics
- Multidrug-Resistant Bacteria2▲ 85×1 topic
- Diagnosis2▲ 4.0×5 topics
- Global Collaboration2▲ 102×1 topic
- Health Biotechnology2▲ 220×1 topic
- Treatment2▲ 3.3×6 topics
- Antiretroviral Therapy1▲ 17×2 topics
- Pathogenesis1▲ 7.0×5 topics
- Antibiotics1▲ 41×2 topics
- Pneumonia1▲ 51×2 topics
- HIV1▲ 25×1 topic
- Pneumocystis1▲ 104×1 topic
- Secondary Metabolites1▲ 29×2 topics
Which research topics does Cempra Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Economic and Financial Impacts of Cancer, Statistical Methods in Clinical Trials, Banking stability, regulation, efficiency and Scientific Computing and Data Management.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
- 2 Statistical Methods in Clinical Trials Statistics and Probability 0 works
- 3 Banking stability, regulation, efficiency Finance 0 works
- 4 Scientific Computing and Data Management Information Systems and Management 0 works
- 5 Research Data Management Practices Information Systems 0 works
- 6 Semantic Web and Ontologies Artificial Intelligence 0 works
- 7 Microfinance and Financial Inclusion Economics and Econometrics 0 works
- 8 Taxation and Compliance Studies Economics and Econometrics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Cempra Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 88% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Chapel Hill
- University of North Carolina at Chapel Hill
- University of North Carolina Health Care
- University of North Carolina Hospitals
- Communities In Schools of Orange County
- Rho (United States)
- Chapel Hill Carrboro City Schools
- Renaissance Computing Institute
- Horizon Research (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.